Harvard Bioscience
HBIO
HBIO
77 hedge funds and large institutions have $78.9M invested in Harvard Bioscience in 2013 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 53 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
64% less call options, than puts
Call options by funds: $5K | Put options by funds: $14K
74% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 53
Holders
77
Holding in Top 10
1
Calls
$5K
Puts
$14K
Top Buyers
| 1 | +$1.85M | |
| 2 | +$1.22M | |
| 3 | +$845K | |
| 4 |
WIC
Woodmont Investment Counsel
Nashville,
Tennessee
|
+$319K |
| 5 |
VDBMI
Van Den Berg Management I
Austin,
Texas
|
+$314K |
Top Sellers
| 1 | -$3.27M | |
| 2 | -$2.21M | |
| 3 | -$2.03M | |
| 4 |
HSA
Hussman Strategic Advisors
Ellicott City,
Maryland
|
-$1.83M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.32M |